期刊論文| 1. | Heidelbaugh, J. J.、Sherbondy, M(2006)。Cirrhosis and chronic liver failure: Part II. Complications and treatment。American Family Physician，74(5)，767-776。   |
| 2. | 王盈文、侯明志(20040300)。自發性腹膜炎的診斷治療及最新發展。臨床醫學，53(3)=315，225-230。 延伸查詢 |
| 3. | 林偉彬、簡榮南(20000900)。成年肝硬化病患之腹水控制原則。當代醫學，27(9)=323，15-20。 延伸查詢 |
| 4. | Coventry, P. A.、Grande, G. E.、Richards, D. A.、Todd, C. J.(2005)。Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review。Age and Ageing，34(3)，218-227。 |
| 5. | Addington-Hall, J.、Fakhoury, W.、McCarthy, M.(1998)。Specialist palliative care in nonmalignant disease。Palliative Medicine，12(6)，417-427。 |
| 6. | 郭集慶、張文豪、柯萬盛、王銘志、吳中興、石季子(20060800)。安寧共同照護之挑戰及因應策略。安寧療護，11(3)，252-262。 延伸查詢 |
| 7. | Cheruvattath, R.、Balan, V.(2007)。Infections in patients with end-stage liver disease。J Clin Gastroenterol，41，403-411。 |
| 8. | Sanchez, W.、Talwalkar, J. A.(2006)。Palliative care for patients with end-stage liver disease ineligible for liver transplantation。Gastroenterol Clin N Am，35，201-219。 |
| 9. | Larson, A. M.、Curtis, J. R.(2006)。Integrating palliative care for liver transplant candidates: Too well for transplant, too sick for life。JAMA，295，2168-2176。 |
| 10. | 霍德義、林漢傑、李壽東(20060500)。Model for End-stage Liver Disease and Organ Allocation in Liver Transplantation: Where are We and Where Shoud We Go?。中華醫學會雜誌，69(5)，193-198+CA38。 |
| 11. | O'Brien, T.、Welsh, J.、Dunn, F. G.(1998)。ABC of palliative care: non-malignant conditions。BMJ，316(7127)，286-289。 |
| 12. | Shah, S.、Blanchard, M.、Tookman, A.、Jones, L.、Blizard, R.、King, M.(2006)。Estimating needs in life threatening illness: a feasibility study to assess the views of patients and doctors。Palliat Med，20，205-210。 |
| 13. | Fitzsimons, D.、Mullan, D.、Wilson, J. S.(2007)。The challenge of patients' unmet palliative care needs in the final stages of chronic illness。Palliat Med，21，313-322。 |
| 14. | Mcllfatrick, S.(2007)。Assessing palliative care needs: views of patients, informal carers and healthcare professionals。J Adv Nurs，57，77-86。 |
| 15. | Murtagh, F. E. M.、Preston, M.、Higginson, I.(2004)。Patterns of dying: palliative care for non-malignant disease。Clinical Medicine，4(1)，39-44。 |
| 16. | Lunney, J. R.、Lynn, J.、Foley, D. J.、Lipson, S.、Guralnik, J. M.(2003)。Patterns of functional decline at the end of life。Journal of the American Medical Association，289(18)，2387-2392。 |
| 17. | Abrahm, J. L.、Hansen-Flaschen, J.(2002)。Hospice care for patients with advanced lung disease。Chest，121，220-229。 |
| 18. | Fox, E.、Landmm-McNiff, K.、Zhong, Z.、Dawson, N. V.、Wu, A. W.、Lynn, J.(1999)。Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease。JAMA，282，1638-1645。 |
| 19. | Christakis, N. A.、Lamont, E. B.(2000)。Extent and determinants of error in doctors, prognoses in terminally ill patients: prospective cohort study。BMJ，320，469-473。 |
| 20. | Dharmasena, H. P.、Forbes, K.(2001)。Palliative care for patients with non-malignant disease: will hospital physicians refer。Palliat Med，15，413-418。 |
| 21. | Wiesner, R. H.、McDiarmid, S. V.、Kamath, P. S.(2001)。MELD and PELD: application of survival models to liver allocation。Liver Transpl，7，567-580。 |
| 22. | Huo, T. I.、Lin, H. C.、Wu, J. C.(2006)。Proposal of a modified Child-Turcotte-Pugh scoring sytem and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis。Liver Transpl，12，65-71。 |
| 23. | Merison, R. M.(2004)。When is a patient too well and when is a patient too sick for a liver transplant?。Liver Transpl，10，69-73。 |
| 24. | Habib, S.、Berk, B.、Chang, C.(2006)。MELD and prediction of post-liver transplantation survival。Liver Transpl，12，440-447。 |
| 25. | Luca, A.、Angermayr, B.、Bertolini, Q.(2007)。An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis。Liver Transpl，13，1174-1180。 |
| 26. | Freeborne, N.、Lynn, J.、Desbiens, N. A.(2000)。Insights about dying from the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments。J Am Geriatr Soc，48(5)，S199-S205。 |
| 27. | Wachter, R. M.、Luce, J. M.、Hearst, N.、Lo, B.(1989)。Decisions about resuscitation: inequities among patients with different diseases but similar prognoses。Ann Intern Med，111，525-532。 |
| 28. | Runyon, B. A.(2004)。Management of adult patients with ascites due to cirrhosis。Hepatology，39，841-856。 |
| 29. | Woolf, S. H.、Sox, H. C. Jr(1991)。The expert panel on preventive services: continuing the work of the U.S Preventive Services Task Force。Am J Prev Med，7，326-330。 |
| 30. | Boyer, T. D.、Haskal, Z. J.(2005)。The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension。Hepatology，41，386-400。 |
| 31. | Garcia-Tsao, Q.、Sanyal, A. J.、Grace, N. D.、Carey, W.(2007)。The Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology: Prevention and management of gastroesophageal varices and variceal hemorrhag。Hepatology，46，922-937。 |
| 32. | Angeli, P.、Volpin, R.、Gerunda, G.(1999)。Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide。Hepatology，29，1690-1697。 |
| 33. | 郭錦松、李發耀(19960300)。肝硬化病人肌肉痙攣的治療。臨床醫學，37(3)=219，185-188。 延伸查詢 |
| 34. | 許煌汶(20051100)。緩和醫學中非癌症慢性疼痛的鴉片類藥物治療。安寧療護，10(4)，384-394。 延伸查詢 |
| 35. | Claria, J.、Kent, J. D.、Lopez-Parra, M.(2005)。Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites。Hepatology，41，579-587。 |
| 36. | Tegeder, I.、Lotsch, J.、Geisslinger, G.(1999)。Pharmacokinetics of opioids in liver disease。Clin Pharmacokinet，37，17-40。 |
| 37. | Westphal, J. F.、Brogard, J. M.(l997)。Drug administration in chronic liver disease。Drug Saf，17，47-73。 |
| 38. | 蘇光中、高嘉宏(20030100)。肝腎症候群。當代醫學，30(1)=351，53-57。 延伸查詢 |
| 39. | Murphy, E. J.(2005)。Acute pain management pharmaecology for the patient with concurrent renal or hepatic disease。Anaesth Intensive Care，33，311-322。 |
| 40. | Murray, K. F.、Carithers, R. L. Jr(2005)。AASLD practice guidelines: evaluation of the patient for liver transplantation。Hepatology，41，1407-1432。 |
| 41. | Antaki, F.、Lukowski, A.(2007)。The model for end-stage liver disease(MELD) predicts survival of liver cirrhosis patients after discharge to hospice。J Clin Gastroenterol，41，412-415。 |
| 42. | Christakis, N. A.、Escarce, J. J.(1996)。Survival of Medicare patients after enrollment in hospice programs。New England Journal of Medicine，335(3)，172-178。 |
| 43. | 胡志棠(20011000)。肝硬化--臨床篇。當代醫學，28(10)=336，70-78。 延伸查詢 |
| 44. | 蔡翊新、林亞陵、黃勝堅(20070800)。重症病患之生命末期照護。安寧療護，12(3)，312-320。 延伸查詢 |